Evidence map›Paper›PMID 32471376›Full record

ArticleBMC infectious diseases2020

Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters.

Carmen L Masson, J Konadu Fokuo, August Anderson, Jesse Powell, Barry Zevin, Dylan Bush, Mandana Khalili

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: A mixed-methods systematic review.Health expectations : an international journal of public participation in health care and health policy · 2022
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Differences in Risks for Recurrent Injury and Death Among Survivors of Violence by Homeless Status.Journal of urban health : bulletin of the New York Academy of Medicine · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Reply.Hepatology communications · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Carmen L MassonDepartment of Psychiatry, University of California San Francisco, Zuckerberg San Francisco General, Hospital and Trauma Center, 1001 Potrero Avenue, Building 20, Suite 2100, San Francisco, CA, 94110, USA. carmen.masson@ucsf.edu.ORCID http://orcid.org/0000-0002-1153-7132
J Konadu FokuoDepartment of Psychiatry, University of California San Francisco, Zuckerberg San Francisco General, Hospital and Trauma Center, 1001 Potrero Avenue, Building 20, Suite 2100, San Francisco, CA, 94110, USA.
August AndersonDepartment of Medicine, University of California San Francisco, Zuckerberg San Francisco General, Hospital and Trauma Center, 1001 Potrero Avenue, NH-3D, San Francisco, CA, 94110, USA.
Jesse PowellHennepin Healthcare, 715 South 8th Street, Minneapolis, MN, 55404, USA.
Barry ZevinStreet Medicine and Shelter Health, at the San Francisco Department of Public Health, 50 Ivy St, San Francisco, CA, 94102, USA.
Dylan BushDepartment of Medicine, University of California San Francisco, Zuckerberg San Francisco General, 1001 Potrero Avenue, NH-3D, San Francisco, CA, 94110, USA.
Mandana KhaliliDepartment of Medicine, University of California San Francisco, Zuckerberg San Francisco General, Hospital and Trauma Center, 1001 Potrero Avenue, NH-3D, San Francisco, CA, 94110, USA.
San Francisco General Hospital · USHennepin Healthcare Research Institute · USSan Francisco Department of Public Health · US

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Substance Use Disorders Treatment/Services Research Training ProgramT32DA007250 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Derek D Satre, Janice Y Tsoh · 1991 to 2026
$7.4M
Mentoring Multidisciplinary Patient-Oriented Research in Viral HepatitisK24AA022523 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KHALILI, MANDANA · 2013 to 2023
$1.9M
Gilead Sciences IN-US-342-4531NIAAA NIH HHS K24 AA022523NIAAA NIH HHS K24AA022523NIDA NIH HHS T32 DA007250NIDA NIH HHS T32DA007250NIDA NIH HHS UG1 DA015815NIDA NIH HHS UG1DA015815
6 · The paper itself

Abstract

backgroundHepatitis C virus (HCV) is highly prevalent among homeless persons, yet barriers continue to impede HCV testing and treatment in this population. We studied the experiences of homeless individuals related to accessing HCV care to inform the design of a shelter-based HCV prevention and treatment program.

methodsHomeless shelter clients (10 women and 10 men) of a large shelter in San Francisco participated in gender segregated focus groups. Focus groups followed a semi-structured interview format, which assessed individual, program/system, and societal-level barriers and facilitators to universal HCV testing and linkage to HCV care. Focus group interviews were transcribed, coded, and analyzed using thematic analysis.

resultsWe identified key barriers to HCV testing and treatment at the individual level (limited knowledge and misconceptions about HCV infection, mistrust of health care providers, co-morbid conditions of substance use, psychiatric and chronic medical conditions), system level (limited advocacy for HCV services by shelter staff), and social level (stigma of homelessness). Individual, system, and social facilitators to HCV care described by participants included internal motivation, financial incentives, prior experiences with rapid HCV testing, and availability of affordable direct acting antiviral (DAA) treatment, respectively.

conclusionsInterrelated individual- and social-level factors were the predominant barriers affecting homeless persons' decisions to engage in HCV prevention and treatment. Integrated models of care for homeless persons at risk for or living with HCV address many of these factors, and should include interventions to improve patient knowledge of HCV and the availability of effective treatments.

Indexed as

Health Plan ImplementationIll-Housed PersonsAdultAgedAntiviral AgentsFemaleHealth PersonnelHepacivirusHepatitis CHepatitis C AntibodiesHousingHumansMaleMiddle AgedPrevalenceSan FranciscoAntiviral AgentsHepatitis C AntibodiesDAA treatmentDrug useFocus groupHCV testingHomelessMental illness

Identifiers

PMID32471376
PMCPMC7260732
OpenAlexW3031210962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.